LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Park, James S"
  2. AU="Han, SeungHye"
  3. AU="Verbić, Tatjana"
  4. AU="Abernethy, David"
  5. AU=Bianchi Claudio
  6. AU="Antonelli, Donna"
  7. AU="Patrick, Anna E"
  8. AU="Philippe J. Guerin"
  9. AU="Oygucu, I Hakan"
  10. AU="Salem, Mohammad"
  11. AU="Lotan, Dor"
  12. AU="Mattingly, M C K" AU="Mattingly, M C K"
  13. AU="Rastogi Ajay"
  14. AU="Deniz Kantar"
  15. AU="Stucky, Cheryl L"
  16. AU="Higashino, Kosaku"
  17. AU="Johnston, Sara C"
  18. AU=Fisayo Temitope
  19. AU="Buret, Laetitia"
  20. AU=Guirao Antonio
  21. AU="Tang, Anthony"
  22. AU="Garnelo, Luiza"
  23. AU=Sakanari J A AU=Sakanari J A
  24. AU="Ni, Fuchuan"
  25. AU="Anithachristy S Arumanayagam"
  26. AU="Melman, Dick"

Suchergebnis

Treffer 1 - 10 von insgesamt 32

Suchoptionen

  1. Artikel ; Online: Continuing Medical Education Questions: September 2021.

    Park, James S

    The American journal of gastroenterology

    2023  Band 116, Heft 9, Seite(n) 1832

    Abstract: Article Title: A scoring model to predict in-hospital mortality in patients with Budd Chiari Syndrome. ...

    Abstract Article Title: A scoring model to predict in-hospital mortality in patients with Budd Chiari Syndrome.
    Sprache Englisch
    Erscheinungsdatum 2023-06-15
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.14309/ajg.0000000000001419
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Revamping hepatitis C global eradication efforts: towards simplified and enhanced screening, prevention, and treatment.

    Pan, Calvin Q / Park, James S

    Translational gastroenterology and hepatology

    2024  Band 9, Seite(n) 30

    Sprache Englisch
    Erscheinungsdatum 2024-03-15
    Erscheinungsland China
    Dokumenttyp Editorial ; Comment
    ISSN 2415-1289
    ISSN (online) 2415-1289
    DOI 10.21037/tgh-23-104
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Continuing Medical Education Questions: March 2021:Pregnancy Outcomes after Liver Transplantation: A Systematic Review and Meta-Analysis.

    Park, James S

    The American journal of gastroenterology

    2021  Band 116, Heft 3, Seite(n) 457

    Abstract: Article Title: Pregnancy Outcomes after Liver Transplantation: A Systematic Review and Meta-Analysis. ...

    Abstract Article Title: Pregnancy Outcomes after Liver Transplantation: A Systematic Review and Meta-Analysis.
    Sprache Englisch
    Erscheinungsdatum 2021-03-03
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.14309/ajg.0000000000001188
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Continuing Medical Education Questions: December 2019.

    Park, James S

    The American journal of gastroenterology

    2019  Band 114, Heft 12, Seite(n) 1837

    Abstract: Article Title: Early Paracentesis in High-Risk Hospitalized Patients: Time for a New Quality Indicator. ...

    Abstract Article Title: Early Paracentesis in High-Risk Hospitalized Patients: Time for a New Quality Indicator.
    Sprache Englisch
    Erscheinungsdatum 2019-12-04
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.14309/ajg.0000000000000471
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Continuing Medical Education Questions: January 2019.

    Park, James S

    The American journal of gastroenterology

    2019  Band 114, Heft 1, Seite(n) 14

    Abstract: To receive CME/MOC credit for this activity, please go to: http://acgjournalcme.gi.org/Article Title: Refractory Ascites in Liver Cirrhosis. ...

    Abstract To receive CME/MOC credit for this activity, please go to: http://acgjournalcme.gi.org/Article Title: Refractory Ascites in Liver Cirrhosis.
    Sprache Englisch
    Erscheinungsdatum 2019-01-10
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.14309/ajg.0000000000000097
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Continuing Medical Education Questions: August 2019.

    Park, James S

    The American journal of gastroenterology

    2019  Band 114, Heft 8, Seite(n) 1195

    Abstract: Article Title: ACG Clinical Guideline: Hereditary Hemochromatosis. ...

    Abstract Article Title: ACG Clinical Guideline: Hereditary Hemochromatosis.
    Sprache Englisch
    Erscheinungsdatum 2019-08-06
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.14309/ajg.0000000000000333
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals.

    Park, James S / Gayam, Vijay / Pan, Calvin Q

    Alimentary pharmacology & therapeutics

    2020  Band 52, Heft 6, Seite(n) 944–954

    Abstract: Background: A critical aspect of liver transplantation in hepatitis B patients is to prevent graft reinfection with hepatitis B virus. The use of hepatitis B immune globulin after transplant was a significant milestone, which allowed prolonged graft and ...

    Abstract Background: A critical aspect of liver transplantation in hepatitis B patients is to prevent graft reinfection with hepatitis B virus. The use of hepatitis B immune globulin after transplant was a significant milestone, which allowed prolonged graft and patient survival by controlling hepatitis B reinfection in liver grafts. The development of anti-viral treatments with oral nucleos(t)ide analogues, led to a further reduction in graft reinfection and improvement in patient survival. The combination of the aforementioned two therapies has been widely used in hepatitis B-associated liver transplants.
    Aims: To address the post-transplant management of hepatitis B and provide updates on preventing graft reinfection.
    Methods: We performed a literature search on Ovid and PubMed for randomised controlled trials or cohort studies in English, which investigated the effectiveness of hepatitis B immune globulin and anti-viral therapy on hepatitis B-associated transplants (1/2000-1/2020). Studies that met pre-established criteria were reviewed.
    Results: Based on currently available evidence, an algorithm for post-transplant management with anti-viral therapy is proposed. Also, the management of recipients who received grafts from hepatitis B core antibody-positive donors is discussed.
    Conclusions: The development of hepatitis B immune globulin and anti-viral treatments led to substantial improvement in graft and patient survival. The prevention of hepatitis B graft reinfection is complex and involves a broad interdisciplinary team.
    Mesh-Begriff(e) Antiviral Agents/therapeutic use ; Hepatitis B/prevention & control ; Humans ; Immunoglobulins/administration & dosage ; Liver Transplantation/methods ; Randomized Controlled Trials as Topic ; Tissue Donors
    Chemische Substanzen Antiviral Agents ; Immunoglobulins ; hepatitis B hyperimmune globulin (XII270YC6M)
    Sprache Englisch
    Erscheinungsdatum 2020-08-03
    Erscheinungsland England
    Dokumenttyp Comparative Study ; Journal Article ; Review
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.15999
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Viral factors for HBV mother-to-child transmission.

    Park, James S / Pan, Calvin Q

    Hepatology international

    2017  Band 11, Heft 6, Seite(n) 476–480

    Abstract: Chronic hepatitis B virus (HBV) remains a leading cause of cirrhosis and hepatocellular carcinoma worldwide. Because chronic hepatitis B infection is rarely eradicated, preventing mother-to-child transmission (MTCT) is the most effective strategy to ... ...

    Abstract Chronic hepatitis B virus (HBV) remains a leading cause of cirrhosis and hepatocellular carcinoma worldwide. Because chronic hepatitis B infection is rarely eradicated, preventing mother-to-child transmission (MTCT) is the most effective strategy to eliminate HBV globally. Although immunoprophylaxis strategy is widely available and effective for infants born to mothers with chronic hepatitis B infection, postnatal immunoprophylaxis fails in approximately 5-10 % of infants, and this failure rate goes up to 30 % in infants born to highly viremic mothers. Mothers with HBV DNA levels above 200,000 IU/mL should be managed aggressively with antiviral therapy because viral load is the strongest independent risk factor for immunoprophylaxis failure. Emerging data suggest that initiation of antiviral therapy in late pregnancy in highly viremic mothers can prevent immunoprophylaxis failure in their infants. Reducing viral load to target levels below 200,000 IU/mL at delivery is a practical approach to control MTCT. This review focuses on viral factors in mothers associated with MTCT.
    Mesh-Begriff(e) DNA, Viral/blood ; Female ; Genotype ; Hepatitis B e Antigens/blood ; Hepatitis B virus/genetics ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/prevention & control ; Hepatitis B, Chronic/transmission ; Humans ; Infant, Newborn ; Infectious Disease Transmission, Vertical ; Mutation ; Pregnancy ; Pregnancy Complications, Infectious/blood ; Pregnancy Complications, Infectious/drug therapy ; Pregnancy Complications, Infectious/virology ; Viral Load
    Chemische Substanzen DNA, Viral ; Hepatitis B e Antigens
    Sprache Englisch
    Erscheinungsdatum 2017-10-12
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2270316-0
    ISSN 1936-0541 ; 1936-0533
    ISSN (online) 1936-0541
    ISSN 1936-0533
    DOI 10.1007/s12072-017-9825-y
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: The importance of community and culture for the recruitment, engagement, and retention of Chinese American immigrants in health interventions.

    Tsai, William / Zhang, Liwei / Park, James S / Tan, Yi-Ling / Kwon, Simona C

    Translational behavioral medicine

    2021  Band 11, Heft 9, Seite(n) 1682–1690

    Abstract: Chinese Americans experience cancer health disparities throughout the entire cancer continuum. Yet, they remain underrepresented in health research in part due to barriers in recruitment, engagement, and retention. This paper describes the strategies ... ...

    Abstract Chinese Americans experience cancer health disparities throughout the entire cancer continuum. Yet, they remain underrepresented in health research in part due to barriers in recruitment, engagement, and retention. This paper describes the strategies that we devised, by drawing upon our experiences with conducting two culturally sensitive cancer intervention studies, to help researchers improve their recruitment and retention rates of Chinese Americans in health research and address the gap in knowledge on intervention research with this population. The first study assessed the efficacy, adoption, and impact of an intervention, delivered by community health workers, to improve adherence to recommended stomach cancer prevention guidelines for at-risk Chinese Americans. The second study evaluated the feasibility and preliminary efficacy of a culturally adapted version of the Expressive Helping intervention for Chinese American cancer patients and survivors. Our main recruitment strategies revolved around building community relationships, developing culturally sensitive materials, and establishing good first impressions with participants. Our main engagement and retention strategies focused on attending to cultural sensitivity, fostering relationships, and using technology. Harnessing the community's inherent strengths and prioritizing cultural understanding is crucial for culturally sensitive health research with Chinese Americans.
    Mesh-Begriff(e) Asian ; Emigrants and Immigrants ; Humans ; Survivors
    Sprache Englisch
    Erscheinungsdatum 2021-05-04
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2586893-7
    ISSN 1613-9860 ; 1869-6716
    ISSN (online) 1613-9860
    ISSN 1869-6716
    DOI 10.1093/tbm/ibab053
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Successful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case Report.

    Arnouk, Serena / Whitsett, Maureen / Papadopoulos, John / Stewart Lewis, Zoe / Dagher, Nabil N / Feldman, David M / Park, James S

    Journal of pharmacy practice

    2022  Band 36, Heft 5, Seite(n) 1260–1263

    Abstract: Nucleoside or nucleotide analogues (NAs) have the potential to cause lactic acidosis by inhibiting DNA polymerase-γ of human mitochondria and impairing aerobic metabolism. Patients may be asymptomatic, have mild non-specific symptoms, or present in ... ...

    Abstract Nucleoside or nucleotide analogues (NAs) have the potential to cause lactic acidosis by inhibiting DNA polymerase-γ of human mitochondria and impairing aerobic metabolism. Patients may be asymptomatic, have mild non-specific symptoms, or present in multisystem organ failure. There is a paucity of data to guide management of life-threatening lactic acidosis due to NA therapy. Here we describe a case of a 60-year old critically ill male with decompensated cirrhosis secondary to hepatitis B virus (HBV) infection who developed severe lactic acidosis (13.8 mmol/L) 2 days after initiation of tenofovir alafenamide (TAF). All other possible etiologies for the elevated lactate were ruled out. Lactic acidosis resolved rapidly with TAF discontinuation and supplementation with cofactors supporting mitochondrial oxidative phosphorylation, including coenzyme Q10, levocarnitine, riboflavin, and thiamine. This case highlights the ability of TAF to cause lactic acidosis early after therapy initiation, especially in susceptible hosts, and reviews the potential role for cofactor supplementation for drug-induced mitochondrial injury.
    Mesh-Begriff(e) Humans ; Male ; Middle Aged ; Tenofovir/adverse effects ; Acidosis, Lactic/chemically induced ; Acidosis, Lactic/diagnosis ; Adenine/therapeutic use ; Hepatitis B/drug therapy ; Antiviral Agents/adverse effects
    Chemische Substanzen Tenofovir (99YXE507IL) ; Adenine (JAC85A2161) ; Antiviral Agents
    Sprache Englisch
    Erscheinungsdatum 2022-05-28
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 1027474-1
    ISSN 1531-1937 ; 0897-1900
    ISSN (online) 1531-1937
    ISSN 0897-1900
    DOI 10.1177/08971900221105042
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang